Contact Us: 01282 426380
KM Financial Solutions | Blackstone invests $2 bln in Alnylam Pharma
70997
post-template-default,single,single-post,postid-70997,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Blackstone invests $2 bln in Alnylam Pharma

12 Apr Blackstone invests $2 bln in Alnylam Pharma

Posted at 11:41h in News by
0 Likes
Blackstone Group Inc said on
Monday it invested $2 billion in Alnylam Pharmaceuticals Inc
through an equity-and-debt deal, giving the drugmaker a
financial boost to develop its experimental therapies.

No Comments

Sorry, the comment form is closed at this time.